CONMED
Buying intent
70 tracked signals | Top 15 topics are below | Sales and HR are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere CONMED's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
5d ago
2d ago
17d ago
16d ago
8d ago
9d ago
2d ago
17d ago
16d ago
9d ago
8d ago
17d ago
16d ago
2d ago
17d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at CONMED
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
See everyone, not just the first 10
23 people across every department at CONMED, plus a LinkedIn profile link for each.
Primary products / business lines
LinkedIn company profileCONMED is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. With products that are recognized as technological leaders by the specialties they serve, healthcare professionals within t
New capability sought
Employee posts (LinkedIn)Company Culture; Employee Engagement; Follow-Up; Healthcare Professionals; Healthcare Providers; Integrated Business Planning; Medical Devices; Patient Safety
Top accounts researching CONMED
names withheld on the public pageThese are companies whose own people brought up CONMED unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
66,174 companies · 318,882 people are researching Hiring
CONMED's own team shows 4 signals on this topic. No one outside CONMED has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Career Development57,400 cos · 377,367 people
- Follow-Up14,433 cos · 44,836 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Sales — 4 people; Marketing — 3 people; Finance — 2 people; HR / Talent — 2 people; Leadership — 1 person; Product — 1 person; Engineering — 1 person
What's been said
public posts mentioning CONMEDUp to 9 public excerpts naming CONMED from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.
The surgical visualization market is shifting fast. The battle is no longer: “Who has the best camera?” Now it is: “Who owns the workflow, ecosystem, and OR experience?” Approximate global positioning across surgical visualization/endoscopy markets today: • Olympus → ~20–25% • Stryker → ~10–15% • Karl Storz → ~8–12% • Medtronic → ~5–8% • Arthrex → ~5–7% and rapidly gaining momentum in arthroscopy visualization • Smith+Nephew → ~4–6% • CONMED → ~2–4% The market trend is becoming increasingly clear: • 4K is now expected • Workflow matters more than specs • Integration is beating standalone towers • Ecosystems are outperforming single-product strategies • Minimally invasive visualization continues accelerating The companies gaining momentum are solving OR friction and building complete procedural ecosystems. At the same time, some legacy players appear to be losing strategic momentum as innovation and differentiation slow relative to the broader market shift — particularly in visualization-focused workflows and ecosystem expansion. The future of surgical visualization is no longer just about image quality. It is about owning the procedure, the workflow, and ultimately the room.
May 2026It was an absolute privilege to join this group of high-performing professionals this week in Athens. Seeing the dedication of the Advanced Surgical and General Surgery teams firsthand makes it clear why they are leaders in the medtech space across Europe, the Middle East, and Africa. The energy in the room is a testament to the leadership of David Kearns and Laurent Lagarde , who continue to drive innovation and a "patient-first" culture throughout the region. From the cutting-edge discussions on AirSeal technology to the commitment to clinical excellence, this team is truly setting the bar. (Thank you for the socks too). Too many names to thank on the EMEA team, but thank you for the warm welcome and the collaboration now and in the future. Ryan Owens continues to teach me and make me better. What an awesome experience to present with him at this meeting. Thank you to Matthew Schabacker, PharmD, MBA and Joe Splinter for making this happen and the feedback to get us ready. And to Stuti Kapadia and Colleen Burns for the teamwork. A huge thank you for the opportunity to speak and share insights with such a talented, forward-thinking group. The lessons learned from the EMEA team and their passion for single digit surgery with the AirSeal system will make us better in the US. We will continue this collaboration in the future for better patient outcomes! Connected ConMed!
Apr 2026Tried and tested in our recent EEMEA 🌍 lab at Orsi Academy !! Now in our FDA regions ❗️ CONMED Orthopedics CONMED Corporation Maria Romeo
Apr 2026